Drugs / Welbutrin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02562430 | Aug 2016 → Aug 2022 | depressive disorder | Massachusetts General Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Welbutrin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02562430 ↗ |